Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C032036 |
bromobenzene |
bromobenzene results in increased expression of GFM1 mRNA | increases expression | 12628495
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of GFM1 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of GFM1 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GFM1 mRNA | affects cotreatment|increases expression | 17942748
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of GFM1 mRNA | decreases expression | 18035473
|
C029424 |
hydrazine |
hydrazine results in increased expression of GFM1 mRNA | increases expression | 15282401
|
D015741 |
Metribolone |
Metribolone results in increased expression of GFM1 protein | increases expression | 17152098
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of GFM1 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GFM1 mRNA | affects cotreatment|increases expression | 17942748
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.99 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.24 | 15322242 11752688 14514962 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.38 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.86 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.77 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.21 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.82 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.82 | 15885639 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.33 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.23 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.93 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.93 | 19244106 19189210 18855134 20544844 19103187 20135344 18351453 19115204 17242785 11161223 16873071 20390343 21152245 19189212 18997820 16202921 20005174 19155303 18984771 19221464 19200415 19011961 18425577 15565566 19410462 17893378 18821012 19142967 19288272 19084267 16273361 18629630 21138602 15668708 17261762 18815881 20065188 19066611 16818667 20859285 17049068 19289846 19487384 19059307 17440819 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.93 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.02 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.87 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
1.85 | 16924424 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.88 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.50 | 16120746 18670907 18850075 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.41 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
3.07 | 17681005 17333356 16105132 11677210 16919318 15861022 17110522 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.20 | 8697196 12621046 15340226 16354765 15668235 |
OMIM:609060 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1 |
marker/mechanism |
|
| |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.31 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 20055451 15322242 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.72 | 19031437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.72 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.72 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
bromobenzene |
4.36 | 10092053 12628495 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
4.36 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.96 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.65 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.35 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
10.06 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
10.06 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.21 | 19155303 17893378 20544844 16202921 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.29 | 9294722 10568697 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
8.64 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
8.64 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.39 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.81 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.92 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.58 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.31 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.04 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.46 | 10048152 11294989 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.62 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.25 | 15340226 12621046 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.49 | 18606429 16354765 8697196 16959395 15340226 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.99 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.17 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.77 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.66 | 17937319 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
9.07 | 17296493 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
9.07 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
9.07 | 12200463 12878042 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
3.27 | 18625569 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.35 | 15342952 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.35 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.35 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
4.69 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.69 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.26 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
2.31 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.31 | 19555203 11884234 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
4.15 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.79 | 11731420 16827153 14580682 19196723 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.99 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.91 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.58 | 15990972 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.24 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.64 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.59 | 19410462 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.44 | 19189210 19200415 19196722 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.54 | 14600291 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.99 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.69 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.89 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.59 | 11399792 11896295 11118676 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.10 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.71 | 15861022 16919318 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.17 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.15 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
13.09 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
13.09 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.43 | 19457130 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.92 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.40 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.35 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
2.44 | 8653321 16712894 17572228 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.63 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.04 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.82 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.69 | 15886252 |